Perelman School Of Medicine University Of Pennsylvania

Women were underrepresented as principal investigators in total hip and total knee arthroplasty clinical trials which may lead to disparities in academic promotion and advancement, according to published results.

In this Healio | Cardiology Today video exclusive, Daniel Soffer, MD, FNLA, discussed some of the highlights so far from the National Lipid Association Scientific Sessions.

Cancers with high vs. low tumor mutational burden appeared significantly associated with improved clinical outcomes among patients treated with immune checkpoint inhibitors, according to data published in JAMA Network Open.

As many as half of cancer-signaling proteins once thought to be resistant to drug treatment due to lack of targetability may, in fact, be treatable, a study conducted at Perelman School of Medicine at the University of Pennsylvania showed.

Carl H. June, MD, will receive this year’s AACR Award for Lifetime Achievement in Cancer Research.

Local administration of chimeric antigen receptor T cells via a fibrin-based gel effectively eliminated leftover cancer cells after incomplete surgical resection, study results published in Science Advances showed.

Only a decade ago, many in oncology considered chimeric antigen receptor T-cell therapy too fringe for real-world use.

A machine learning algorithm that triggered electronic reminders to health care providers increased the rate at which providers and patients spoke about end-of-life care preferences, according to randomized trial results.

In a scientific statement, the American Heart Association issued guidance on the epidemiology, diagnosis and management of cancer therapy-induced hypertension.

Dazodalibep has successfully improved disease activity and symptoms two patient populations with Sjögren’s syndrome in a phase 2 trial, according to a press release from Horizon Therapeutics.